Tag Archives: n

Top Tech Stocks To Own For 2021

What happened

Abiomed (NASDAQ:ABMD) stock jumped 10.6% in September, according to data fromS&P Global Market Intelligence. For context, theS&P 500 returned0.6% last month.

Shares of the minimally invasive heart pump maker, however, have given back those gains already in October. Through Oct. 10, the stock is down 16.6%. Unlike last month’s movement, which was due to company-specific news, this month’s sell-off appears to be a casualty of the broader market’s struggles. The S&P 500 and the tech-heavy Nasdaq Composite are in the red 4.4% and 7.8%, respectively,....More>>>

Top 10 Heal Care Stocks To Invest In 2019

A steep slowdown in demand from cryptocurrency miners is tempering enthusiasm for what in many ways is a strong Nvidia (NVDA)  earnings report.

After the bell on Thursday, Nvidia reported April quarter (fiscal first quarter) revenue of $3.21 billion (up 66% annually) and GAAP EPS of $1.98, handily beating consensus analyst estimates of $2.89 billion and $1.46. All five of Nvidia’s reported market segments — Gaming, Datacenter, Automotive, Professional Visualization and OEM & IP — beat consensus revenue estimates.

Nvidia also guided for July quarter revenue....More>>>

Hot Low Price Stocks To Watch Right Now

Heart diseasestill claims the lives of around 600,000 Americans every year, and uncontrollable cholesterol plays a big role.EsperionTherapeutics Inc. (NASDAQ:ESPR)became oneof2017’s best-performing biotech stocks because it’s developing a drug that could lower this number.

Unfortunately, Esperion recently revealed some disturbing safety data from one of several ongoing late-stage clinical trials. The stock price was quickly cut in half, and there’s still a chance it could come back in a big way.

Does that make this risky biotech a buy on the dip?Let’s weigh....More>>>

Top 10 Heal Care Stocks To Buy Right Now

After examining Walt Disney’s (DIS) earnings, which were released after yesterday’s market close, Stifel’s Benjamin Mogil and Kevin Lee Hon Siong argued that they “continue to view Disney as a Tale of Two Stories.” They explain why:

Getty Images

Disney reported 4Q16 results which were in-line with our estimates but below those of consensus expectations. Commentary for 2017 was likely below expectations but at the same set the stage for more realistic expectations and we view that clarity/transparency as one of the bigger factors behind the after-market....More>>>